Team
We are an enthusiastic group of scientists working on the fringes of chemistry, biochemistry, chemical-biology, molecular biology and synthetic biology.
Hyperdrive Science team
Professor Peter Karuso PhD, FRNS FRACI Co-Founder and CEO
PhD in Chemistry with 35 years experience in science and co-founder of Fluortechnics Pty Ltd. Where he served as CSO for six years. He is internationally renowned for expertise in natural products chemistry, very early stage drug discovery and phage display. Over the past 15 years he has developed the concept of “reverse chemical proteomics” upon which Hyperdrive is based.
Fei Liu PhD MRACI Co-Founder and CMO CBDO
After doctoral training at Yale and post-doctoral training as an NIH fellow at Harvard, Dr Fei Liu moved to Australia and is currently a senior lecturer in synthetic chemistry and chemical proteomics at Macquarie University. Her expertise is in synthesis and biosynthesis of bioactive compounds and natural products, identification of drug leads and targets, and mode-of-action characterization in network pharmacology.
Paul Jaschke PhD Co-Founder and CSO
Dr Jaschke is a lecturer in synthetic biology at Macquarie University. He has consulted for US startup GeneWEAVE, developing novel diagnostic technologies using bacteriophage. During his postdoctoral fellowship at Stanford, Jaschke was a member of the Stanford Biotechnology Group and worked at AutoDesk Inc. that enables scientists to design workflows on cloud lab services.
Kavita Ragini PhD Co-Founder and COO
Kavita has hands on expertise in phage display and biopanning – the process of iteratively isolating the protein partner of drug leads. Her PhD was in natural products chemistry and phage display. Kavita manages the science team in charge of the identification of drug binding proteins and Hyperdrive operations.